First Horizon Advisors, Inc.
- SEC CIK
- 0001588539
- Latest filing
- Aug 6, 2025
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by First Horizon Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −863−100.0% | Sold out | Holders |
| Q3 2024 | 863 | $24.9K | <0.1% | −33−3.7% | Reduced | Holders |
| Q2 2024 | 896 | $34.4K | <0.1% | +185+26.0% | Added | Holders |
| Q1 2024 | 711 | $41.8K | <0.1% | +39+5.8% | Added | Holders |
| Q4 2023 | 672 | $40.2K | <0.1% | +23+3.5% | Added | Holders |
| Q3 2023 | 649 | $24.7K | <0.1% | +265+69.0% | Added | Holders |
| Q2 2023 | 384 | $35.0K | <0.1% | +29+8.2% | Added | Holders |
| Q1 2023 | 355 | $23.4K | <0.1% | +355 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −4−100.0% | Sold out | Holders |
| Q3 2021 | 4 | $0 | 0.0% | +4 | New | Holders |